previous compound ID: 1285 next compound
InChIKey: LNEPOXFFQSENCJ-UHFFFAOYSA-N
SMILES: C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "GW Carlile" "SD Macknight" "DY Thomas" "R Robert" "J Goepp" "B Kus" "JW Hanrahan" "E Matthes" "J Liao"

chemical graph of compound 1285





CID is 3559
synonyms found at PubChem are:
haloperidol, 52-86-8, Haldol, Aloperidin, Serenace, Aloperidol, Brotopon, Eukystol, Einalon S, Aloperidolo, Galoperidol, Halojust, Halopoidol, Serenase, Serenelfi, Ulcolind, Uliolind, Vesalium, Halopal, Linton, Mixidol, Pernox, Sernas, Sernel, Dozic, Aldo, Lealgin compositum, Keselan, Peluces, Bioperidolo, Haloperidolum, Sigaperidol, Haldol Solutab, McN-JR-1625, Aloperidon, Fortunan, Halosten, Aloperidolo [DCIT], Halidol, Halopidol, Pekuces, Halol, Aloperidolo [Italian], Haloperidolum [INN-Latin], 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one, Haloperido, Peridol, Dozix, R 1625, R-1625, Apo-Haloperidol, Pms Haloperidol, Novo-Peridol, Haldol La, C21H23ClFNO2, 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine, NSC 170973, UNII-J6292F8L3D, Haldol (TN), CCRIS 1630, Haloperidol (Haldol), 4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone, 4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone, HSDB 3093, Haloperidol lactate, Haloperidol [USAN:INN:BAN:JAN], CHEMBL54, EINECS 200-155-6, NSC 615296, 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone, BRN 0331267, 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-, 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, MLS000028450, CHEBI:5613, LNEPOXFFQSENCJ-UHFFFAOYSA-N, 4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone, 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, J6292F8L3D, Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-, Haloperidol Intensol, 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-, 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one, IN1474, NSC170973, NSC615296, CAS-52-86-8, NCGC00015500-10, SMR000058303, 4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone, 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone, 4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone, Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-, gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one, H 1512, DSSTox_CID_14150, DSSTox_RID_79117, DSSTox_GSID_34150, W-105791, haloperin, Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-, gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one, 177716-59-5, 61788-97-4, SR-01000003076, Haloperidol (JP15/USP), Duraperidol, Resin epoxy, 4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone, gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone, 4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone, Picroside-III, Haloperidol, 1, Aloperidin (TN), Bioperidolo (TN), Duraperidol (TN), Sigaperidol (TN), Brotopon (TN), Eukystol (TN), Halosten (TN), Serenace (TN), Serenase (TN), Haloperidol, powder, Prestwick_250, Keselan (TN), Peluces (TN), Phenolic epoxy resin, Linton (TN), Einalon S (TN), Dozic (TN), Haloperidol [USAN:USP:INN:BAN:JAN], MDMO-PPV, Spectrum_000861, Tocris-0931, Opera_ID_446, 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl), Prestwick0_000115, Prestwick1_000115, Prestwick2_000115, Prestwick3_000115, Spectrum2_001268, Spectrum3_000448, Spectrum4_000570, Spectrum5_000788, Lopac-H-1512, Biomol-NT_000035, D0D1AL, GTPL86, Probes1_000255, Probes2_000296, AC1L1G7K, SCHEMBL8264, Lopac0_000583, Oprea1_509923, BSPBio_000130, BSPBio_002096, KBioGR_000980, KBioGR_002390, KBioSS_001341, KBioSS_002395, 5-21-02-00377 (Beilstein Handbook Reference), MLS001146904, BIDD:GT0128, DivK1c_000654, SPECTRUM1500325, SPBio_001236, SPBio_002069, McM-JR-1625, AC1Q77Z0, BPBio1_000144, BPBio1_001231, Haloperidol (JP15/USP/INN), Haloperidol (JP17/USP/INN), DTXSID4034150, BDBM21398, HMS502A16, KBio1_000654, KBio2_001341, KBio2_002390, KBio2_003909, KBio2_004958, KBio2_006477, KBio2_007526, KBio3_001316, KBio3_002869, LNEPOXFFQSENCJ-UHFFFAOYSA-, AOB5645, cMAP_000037, MolPort-000-883-311, NINDS_000654, AC250, HMS1568G12, HMS1920D03, HMS2089M15, HMS2091J09, HMS2095G12, HMS2234P08, HMS3261F08, HMS3370H11, HMS3657I13, HMS3712G12, Pharmakon1600-01500325, ZINC537822, Haloperidol 1.0 mg/ml in Methanol, Tox21_110162, Tox21_300475, Tox21_500583, A0H334, BG0211, CCG-36042, CCG-39111, MFCD00051423, NSC757054, STL417208, AKOS000280660, Tox21_110162_1, API0002885, CS-1971, DB00502, LP00583, MCULE-3693790133, NSC-170973, NSC-615296, NSC-757054, IDI1_000654, MRF-0000027, QTL1_000042, WLN: T6NTJ A3VR DF& DQ DR DG, NCGC00015500-01, NCGC00015500-02, NCGC00015500-03, NCGC00015500-04, NCGC00015500-05, NCGC00015500-06, NCGC00015500-07, NCGC00015500-08, NCGC00015500-09, NCGC00015500-11, NCGC00015500-12, NCGC00015500-13, NCGC00015500-14, NCGC00015500-15, NCGC00015500-16, NCGC00015500-17, NCGC00015500-19, NCGC00016234-01, NCGC00023875-02, NCGC00023875-04, NCGC00023875-05, NCGC00023875-06, NCGC00023875-07, NCGC00023875-08, NCGC00023875-09, NCGC00254503-01, NCGC00261268-01, AC-19691, AN-41634, CC-16450, HY-14538, KB-79571, LS-48311, SC-81035, ACM1189986591, SBI-0050565.P004, AB2000375, SC 170973, TR-018722, AB00052008, EU-0100583, FT-0669100, FT-0697842, N1910, S1920, ST50319916, W0039, 4763-EP2269989A1, 4763-EP2269990A1, 4763-EP2272537A2, 4763-EP2272972A1, 4763-EP2272973A1, 4763-EP2275420A1, 4763-EP2277872A1, 4763-EP2277876A1, 4763-EP2292614A1, 4763-EP2295061A1, 4763-EP2295412A1, 4763-EP2295413A1, 4763-EP2295439A1, 4763-EP2298731A1, 4763-EP2298776A1, 4763-EP2305260A1, 4763-EP2308867A2, 4763-EP2308870A2, 4763-EP2311801A1, 4763-EP2311803A1, 4763-EP2311824A1, 4763-EP2311837A1, 4763-EP2316834A1, C01814, D00136, VU0239704-10, AB00052008-21, AB00052008-22, AB00052008_23, AB00052008_24, C-35402, L000288, SR-01000003076-2, SR-01000003076-8, BRD-K67783091-001-04-8, BRD-K67783091-001-05-5, BRD-K67783091-003-03-6, I14-13404, I14-14165, SR-01000003076-11, Haloperidol, European Pharmacopoeia (EP) Reference Standard, Poly[2-methoxy-5-(3,7-dimethyoctyoxyl)-1,4-phenylenevinylene], .gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone, Haloperidol, United States Pharmacopeia (USP) Reference Standard, .gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, 4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-one, Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material, 4-[4-(4-Chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)- 1-butanone, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone, Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard, Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard, InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2